Juvenile dermatomyositis, a uncommon however usually extreme and persistent systemic autoimmune illness, contains a lot of sufferers who’re therapy resistant, requiring long run immunosuppressive remedy. A small examine reveals promise utilizing a focused biologic remedy referred to as abatacept to deal with such sufferers.